Today: Nov 22, 2024

Schizophrenia

AbbVie stocks tumble after schizophrenia drug disappoints

AbbVie stocks tumble after schizophrenia drug disappoints

AbbVie stocks tumble after schizophrenia drug disappoints  Monetary TimesAbbVie Inventory Tumbles on Failed Schizophrenia Drug Research. Bristol Myers Jumps.  Barron’sBristol Soars 11% As Traders Query AbbVie’s Expensive ‘Mistake’  Investor’s Industry DailyAbbVie Inventory Sinks After Schizophrenia
November 11, 2024
1 2 3 5